Search - tctmd.com

Displaying 461 - 480 of 872

Sort: Relevancy | Date

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News ESC 2018

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

Caitlin E. Cox

September 07, 2018

News Conference News ESC 2018

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Shelley Wood

August 31, 2018

News Conference News ESC 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

Todd Neale

August 30, 2018

News Daily News

DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

L.A. McKeown

August 30, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

Presentation CHIP Seattle 2018

Rotational Burr Broke Wire and Left the Coronary Artery

Presenter: Steven P. Marso

August 11, 2018

$A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years$

News Daily News

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Yael L. Maxwell

August 10, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

L.A. McKeown

June 22, 2018

News Daily News

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

Caitlin E. Cox

June 06, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Michael O'Riordan

May 29, 2018

Advertisement

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

FFRCT Shifts Patient Management, Linked to Better 90-Day Outcomes: ADVANCE Registry

SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

DET02X-AMI: Oxygen Takes Another Hit as More Data Show No Pain Relief During PCI

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Rotational Burr Broke Wire and Left the Coronary Artery

A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Once Again, ISCHEMIA Trial Feels the Squeeze

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

Advent of High-Sensitivity Troponin Tests in Sweden Leads to Only Small Uptick in MI Diagnoses

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Excellent Procedural Success Seen With Left Distal Access of Radial Artery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content